Key result
Genetic variants near BDKRB2, NELL1, and CPN2 (rs5224, rs8176786, rs10766756, and rs4974539) were significantly associated with both overall ACEI-related adverse events and ACEI-related cough.
Why the study?
Are specific genetic variants associated with adverse events after ACEI use in the Korean population?
Case-Control (n=564)
No
Are specific genetic variants associated with adverse events after ACEI use in the Korean population?
Answers are grounded in this paper and cite their sources.
Several genetic variants, including SNPs near BDKRB2, NELL1, and CPN2, are significantly associated with ACEI-related adverse events such as cough in the Korean population, providing pharmacogenomic insights for safer prescribing.
Purpose: Angiotensin-converting enzyme inhibitors (ACEIs) are medications generally prescribed for patients with high cardiovascular risk; however, they are suboptimally used due to frequent adverse events (AEs).The present study aimed to identify and replicate the genetic variants associated with ACEI-related AEs in the Korean population. Materials and Methods:A two-stage approach employing genome-wide association study (GWAS)-based discovery and replication through target sequencing was used.In total, 1300 individuals received ACEIs from 2001 to 2007; among these, 228 were selected for GWAS.An additional 336 patients were selected for replication after screening 1186 subjects treated from 2008 to 2018.Candidate genes for target sequencing were selected based on the present GWAS, previous GWASs, and data from the PharmGKB database.Furthermore, association analyses were performed between no AE and AE or cough groups after target sequencing.Results: Five genes, namely CRIM1, NELL1, CACNA1D, VOPP1, and MYBPC1, were identified near variants associated with ACEIrelated AEs.During target sequencing of 34 candidate genes, six single-nucleotide polymorphisms (SNPs; rs5224, rs8176786, rs10766756, rs561868018, rs4974539, and rs10946364) were replicated for association with all ACEI-related AEs.Four of these SNPs and rs147912715 exhibited associations with ACEI-related cough, whereas four SNPs (rs5224, rs81767786, rs10766756, and rs4974539 near BDKRB2, NELL1, NELL1 intron, and CPN2, respectively) were significantly associated with both categories of AEs.Conclusion: Several variants, including novel and known variants, were successfully replicated and found to have associations with ACEI-related AEs.These results provide rare and clinically relevant information for safer use of ACEIs.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2022) conducted a case-control in Angiotensin-converting enzyme inhibitor (ACEI)-related adverse events (n=564). Genetic variants (SNPs in BDKRB2, NELL1, CPN2) vs. Non-carriers / wild-type was evaluated on Association of single-nucleotide polymorphisms with ACEI-related adverse events (p=<0.05). Genetic variants near BDKRB2, NELL1, and CPN2 (rs5224, rs8176786, rs10766756, and rs4974539) were significantly associated with both overall ACEI-related adverse events and ACEI-related cough.
Synapse has enriched 10 related papers. Consider them for comparative context: